I bring more than 20 years of drug discovery and early development experience across a range of therapeutic areas, including inflammation, gastrointestinal, neurodegeneration, psychiatry and dermatology. I have held leadership roles at Shire, AstraZeneca, Merck , Calcico Therapeutics, Chronos Therapeutics & Polleo Pharma.

Prior to co-founding Polleo Pharma and raising investment to fund the portfolio, I was Senior Director and Head of Discovery Biology for Shire Speciality Pharmaceuticals, focused on CNS and GI disorders.

I hold a PhD from The School of Pharmacy UCL, a BSc from the University of Strathclyde and an MBA from Alliance Manchester Business School